Corporate News

George Clinical Client Noxopharm Announces Chemotherapy Enhancement Program Expansion

Noxopharm, a clinical-stage Australian drug development company currently working with George Clinical, is seeking to establish Veyonda®, an innovative dosage formulation of the experimental anti-cancer drug idronoxil, as “an essential adjunct to all forms of radiotherapy in the treatment of prostate cancer, both late-stage and early-stage prostate cancer,” according to an announcement last week. Through […]

Read More

April 20th, 2019

George Clinical Scientific Leader Named Chief Medical Officer of OneOncology

OneOncology, a national partnership of community oncologists, recently announced that Lee Schwartzberg, MD, FACP, a member of the George Clinical scientific leadership committee, has been named Chief Medical Officer (CMO). According to OneOncology, the CMO position “provides a dynamic link between OneOncology and its physician partners, demonstrating the shared, foundational commitment to a physician-driven, data-driven, technology-powered, […]

Read More

April 17th, 2019

Late Breaking Clinical Trial CREDENCE Webcast to Stream this Month

ISN World Congress of Nephrology will be live streaming “Late Breaking Clinical Trials” from WCN 2019. The purpose of the webcast is to give the worldwide nephrology community in-depth understanding of three major nephrology studies, including the CREDENCE study for which George Clinical plays a critical role.   The session will be streamed live from […]

Read More

April 5th, 2019

George Clinical Strengthens Asia-Pacific Presence with New Singapore Location

George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in Asia with the addition of a new presence in Singapore. The new office and entity in Singapore, which was established in July, were requisites for George Clinical to act as a local clinical trial sponsor for the firm’s international client […]

Read More

April 2nd, 2019
Dr. Maria Ali

George Clinical Promotes Maria Ali to the Role of Chief Medical Officer

OVERLAND PARK, KS, March 6, 2019 George Clinical, a leading Asia-Pacific based clinical research organization (CRO) with global capabilities, today announced that Dr. Maria Ali has been promoted to Chief Medical Officer to be based out of Raleigh, North Carolina. This move further solidifies the strategic growth of George Clinical throughout North America and recognizes […]

Read More

March 6th, 2019

George Clinical Congratulates Parent Company The George Institute For Global Health For Securing $12 Million To Tackle Worlds Biggest Killers

[Sydney, Australia] George Clinical congratulates its parent company, The George Institute for Global Health for securing $12 million from the National Health and Medical Research Council (NHMRC), Australia’s peak funding body for medical research. These grants will support The Institute’s scientific leaders to improve the lives of people living with chronic kidney disease, septic shock […]

Read More

February 12th, 2019

George Clinical’s Parent Company The George Institute For Global Health Secures Largest Ever NHMRC Project Grant To Benefit People With Kidney Disease

George Clinical congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) globally and benefit millions of people globally. The $5.5 million awarded by the National Health and Medical Research Council (NHMRC), Australia’s peak funding body for medical research, is […]

Read More

February 5th, 2019

George Clinical Scientific Leader research contributions recognized with leading Lancet profile.

George Clinical welcomes the recognition of Professor Craig Anderson as profiled in the premier medical journal The Lancet which identified him as “a front runner in stroke research”. “It is our engagement with scientific leaders, such as Professor Anderson, that sets George Clinical apart from other CROs,” said Philip Gregory, Managing Director, China. “The Lancet […]

Read More

January 29th, 2019

George Clinical Welcomes WCC Partnership with OneOncology

George Clinical welcomes the recent announcement by our partner organization, West Cancer Center of their intention to join OneOncology in January 2019. The announcement sees a departure from their existing relationship with Methodist Le Bonheur Healthcare, an affiliation they have held since 2011. The affiliation with OneOncology will place West Cancer Center as a nationally […]

Read More

January 29th, 2019

George Clinical announces the appointment of James Cheong to the role of Chief Operating Officer

SYDNEY, January 22, 2019 – George Clinical, headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief Operating Officer. With extensive management experience spanning over two decades, Cheong brings valuable leadership to George Clinical’s executive team during a period of strong expansion and growth. […]

Read More

January 22nd, 2019
George Clinical

customerservice@georgeclinical.com

Profits from George Clinical support the work of The George Institute for Global Health.

Join our Mailing List

Add George Clinical to your network